Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival (CROSBI ID 293184)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

(International Oncology Panel ; FAVO ; ECPC) Mauri, Davide ; Tzachanis, Dimitrios ; Valachis, Antonis ; Kamposioras, Konstantinos ; Tolia, Maria ; Dambrosio, Mario ; Zarkavelis, Georgios ; Gkoura, Stefania ; Gazouli, Ioanna ; De Lorenzo, Francesco et al. Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival // JBUON, 25 (2020), 3; 1277-1280

Podaci o odgovornosti

Mauri, Davide ; Tzachanis, Dimitrios ; Valachis, Antonis ; Kamposioras, Konstantinos ; Tolia, Maria ; Dambrosio, Mario ; Zarkavelis, Georgios ; Gkoura, Stefania ; Gazouli, Ioanna ; De Lorenzo, Francesco ; Apostolidis, Kathi ; ... ; Antunac, Katarina ; Dedić Plavetić, Natalija

International Oncology Panel ; FAVO ; ECPC

engleski

Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival

To protect cancer patients from COVID-19 exposure, prioritization strategies are being implemented at global level. Measures include use of telehealth services, deferring elective surgeries, delaying non life-saving therapies, interrupting maintenance and supportive care regimens and suspending screening and regular follow-up visits. Nonetheless, the risk of infection may not always outweigh oncology treatment benefit. Lives of most oncology patients depend on their ability to receive medical, surgical and radiotherapy care. Postponing screening, follow-up and radical surgeries increase patients’ risk of developing metastatic disease. A viral pandemic lasts long time and exhibits seasonal and geographical variations. Though vaccines will be available only in the 2021, a global, aggressive, all-embracing and protracted slowdown of oncologic activities will severely jeopardize patients’ outcomes. A present international oncologists’ panel, ECPC and FAVO, strongly suggest that Hospital measures in a specific geographical area/Nation should be in line with the local epidemic, and restrictions adopted should be adapted and stratified over time.

COVID-19 ; cancer patients ; survival ; Federation of Oncology Volunteer Associations (FAVO) ; European Cancer Patient Coalition (EPCC)

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

25 (3)

2020.

1277-1280

objavljeno

2241-6293

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost